Apocalypse Suicide Page
Good Mood
Living with Depression
Mental Health Recovery
NIMH
SHOCKED! ECT

HealthyPlace.com Radio
Depression Support Groups

Books on Depression
Conference Transcripts
Depression Videos
Diaries - Journals
Disorders Definitions
Mental Health News
Online Depression Tests
Psychiatric Medications
Resources
Site Map

Email
ICQ
Instant Messenger

Visit and Post

Abuse
ADD/ADHD
Addictions
Anxiety-Panic
Bipolar
Eating Disorders
Personality Disorders
Self-Injury

 

send this page to a friend


 

Treating Depression in Women

Treatment Principles

HealthyPlace.com Video

watch this video Overcoming Depression: An Overview of Treatment Strategies

In addition to confirming the diagnosis of depression and evaluating suicide risk, the physician should identify any relationship between depression and menstruation, pregnancy, the postpartum period or the perimenopausal period. A possible relationship between depression and medications such as birth control pills or agents used in hormone replacement therapy must also be explored. If there is a link to any treatable cause of depression, it should be addressed first. If the patient's depression does not respond to this intervention, further treatment is required.

More Info

Undoing Depression: What Therapy Doesn't Teach You and Medication Can't Give You

Choosing a Psychotherapist

Psychosocial and pharmacologic treatments may be considered. Psychosocial therapies should address issues that particularly affect women, such as competing roles and conflicts. Commonly used treatments include psychotherapy to correct interpersonal conflicts and to help women develop interpersonal skills; cognitive-behavioral therapy to correct negative thinking and associated behavior; and couples therapy to reduce marital conflicts. In patients with mild to moderate depression, psychosocial therapies may be used alone for a limited period, or they may be used in conjunction with antidepressant medication.

The pharmacokinetics of antidepressant drugs differ somewhat in men and women (Table 5). Thus, standard pharmacotherapy may have to be modified for use in female patients. Currently, little is known about these pharmacokinetic differences because many more men than women have participated in investigational drug studies. Nonetheless, certain gender-related differences merit consideration.

Absorption of antidepressants may be enhanced in women because they secrete less gastric acid than men. In addition, gastrointestinal transit time may be slower in women, especially during high progesterone phases of the reproductive cycle. This slower transit time may also enhance the absorption of antidepressant medications. Another difference is the higher ratio of body fat to muscle in women; this ratio becomes even greater with age and increases the volume of distribution for many drugs. Finally, progesterone increases microsomal and monoamine oxidase enzyme activity, whereas estrogen decreases this activity; these actions affect monoamine neurotransmitters and drug metabolism.

advertisement

Because of these biologic differences, antidepressant plasma concentrations may be higher in women. Thus, female patients with depression may require lower dosages of antidepressants than their male counterparts. Women may also experience drug side effects more frequently. Although women frequently experience sexual side effects, they generally do not report these effects unless specifically asked.

Depression: Antidepressant Pharmacological and Treatment-Related Differences in Women Compared with Men

Physical properties
Differences in women compared with men

Frequency of seeking help

May be greater

Absorption of antidepressant

Greater

Ratio of body fat to muscle

Greater

Volume of drug distribution

Larger

Plasma concentration of antidepressant

May be higher

Antidepressant dosage

May need to be lower

Side effects of antidepressants

More frequent

Effect of progesterone

Increased microsomal and monoamine oxidase enzyme activity with decreased monoamine neurotransmitters

Effect of estrogens

Decreased microsomal and monoamine oxidase enzyme activity with increased monoamine neurotransmitters

Duration of therapy

May need to be longer

Efficacy of cognitive-behavioral and interpersonal therapy

Similar

Efficacy of combined medication and psychotherapy

Similar or may be greater

Need for treatment of comorbid anxiety, panic, phobic and eating disorders

Greater

Need for thyroid screening

More frequent

 

RELATED LINKS AND INFO

Depression in Women - Overview
Depression: What Every Woman Should Know
Risk Factors for Depression in Women
Depression and the Lifetime Reproductive Cycle
The Role Hormones Play in Mood Disorders
Pregnancy and Antidepressants
Antidepressant Medication Safe During Pregnancy
Antidepressant Medication Side-Effects in Postpartum Depression
Latest Research Findings on Women and Depression

top ~ next ~ send page to a friend


  HealthyPlace.com Depression Center Links
home ~ site map ~ causes ~ types ~ people ~ living with
treatments ~ self-help ~ support ~ suicide ~ related issues

 
   


 

     

HealthyPlace.com Homepage
Chat ~ Forums ~ Communities
HealthyPlace.com Films ~ HealthyPlace.com Radio ~ News
Site Map ~ Web Tour ~ Advertise ~ Email Us
send this page to a friend

We subscribe to the HONcode principles of the Health On the Net Foundation.

© 2000-2006 HealthyPlace.com, Inc. All rights reserved.
Terms of Use Privacy Policy Disclaimer Advertising Policy